The association between acute pancreatitis and severe hypertriglyceridemia has long been recognized. We report two cases of severe primary hypertriglyceridemia (types 1 and V) with recurrent acute pancreatitis. In both patients, observance of appropriate diet and drug therapy was insufficient. Recurrent episodes of pancreatitis were precipitated by dietary fat or alcohol abuse. A plasmapheresis was performed every 4 weeks to decrease the incidence of pancreatitis. It appears that plasmapheresis is a safe and highly effective method for quickly removing serum triglycerides. Moreover, plasmapheresis may be useful for preventing acute pancreatitis.
glyceridemia remain > 11.3 mM (1000 mg/dl) in spite of diet and/or drug therapy.
Extracorporeal elimination of lipoproteins is useful in rapidly lowering elevated serum triglycerides. This method has been employed with success in patients with acute pancreatitis (7) (8) (9) and in pregnant women with hypertriglyceridemia-induced pancreatitis (10) (11) (12) .
We report the first use of repetitive plasmapheresis in two cases of severe primary hypertriglyceridemia and recurrent acute pancreatitis without biliary tract disease. We investigated whether this treatment affects the incidence of acute pancreatitis. Table 1 shows the clinical characteristics of patients. As soon as the diagnosis was known, a very low fat diet (<20 g/day) was introduced in patient 1 with type I hyperlipoproteinemia. He responded to restricted fat and the observance was good for a few years. Patient 2 presented a type V hyperlipoproteinemia. Unfortunately, he never accepted an appropriate diet (hypocaloric regimen, alcohol restric- tion). In spite of drug therapy (fibrates), triglyceride levels remained high. He reported recurrent headaches and dizziness with lightheaddedness and vertigo independently of alcohol consumption. These symptoms were accompanied by mood disturbances including dysphoria and depression. Neurologic examination was normal.
CASE REPORTS
For each acute pancreatitis episode, age of patient, triglyceride level on admission, potential contributing factors, Ranson's criteria (13), and computed tomography grade according to Ranson et al. (14) are given in Table 2 . Amylase or pancreatic lipase levels are not mentioned because it has been shown that severe hypertriglyceridemia interferes with the assay for enzyme determination in both serum and urine (15) . In both patients, each acute pancreatitis was treated by eliminating oral intake, lowering triglyceride levels with emergency plasmapheresis, instituting intravenous hydration, and providing parenteral analgesia. No surgical treatment was required.
METHODS
We used a continuous-flow blood cell separator (therapeutic plasmapheresis Dideco 480N/400). The blood flow rate was adjusted to 30-70 ml/min. A peripheral venovenous approach was only necessary. Between 1 and 1.5 plasmatic mass was withdrawn at each procedure. Plasma was substituted with a solution of 4% human albumin. Coagulation was prevented with heparin (infusion of 50 IU/kg at the onset of the procedure). Hypocalcemia was prevented with an intravenous injection of 10% calcium gluconate before each procedure (1,000 mg). Plasmapheresis was performed every 4 weeks in the outpatient clinic, except during holidays. Each procedure lasted on average 3 4 h, after which the patient was released.
Blood samples were taken from a peripheral vein before the plasma exchange (following a 12-h overnight fast) and just after the procedure. Triglyceride and total cholesterol levels were obtained for each patient. Total cholesterol and triglyceride concentrations were determined by enzymatic analysis.
Statistical analysis
Values are means * standard deviations. The differences between before and after procedure values were calculated using the paired Student test. Differences were considered significant at a probability value of <0.05.
RESULTS
For each patient, the follow-up was, respectively, 37 and 38 months. Table 3 gives the means of triglyceride and cholesterol levels before and just after the plasma exchanges. The mean triglyceride level was lowered by 70%.
There was no side effect during and after each plasma exchange. Patients developed neither infections nor bleeding. Patient 2 did not report dizziness, vertigo, and headaches during the days following plasmapheresis procedure. Acute pancreati- tis occurred in patient 1 after a follow-up of 32 months. This episode was precipitated by dietary fat abuse during the Christmas period. The triglyceride level on admission was 51 mM (4,510 mg/dl). Following this pancreatitis, the patient developed insulin-dependent diabetes and a deficit of external pancreatitis function.
DISCUSSION
Triglyceride levels are classified as normal (<2.3 mM or 200 mg/dl), borderline-high (2.3-4.5 mM, 200400 mg/dl), high (4.5-1 1.3 mM, 400-1,000 mg/ dl), and very high (11.3 mM, 1,000 mg/dl) (16) . Patients with triglyceride levels > l l .3 mM ( 1,000 mg/ dl) are at increased risk for acute pancreatitis (3,4). Our experience suggests that the risk is major with triglyceride levels >25 g/L (2,825 mg/dl). Most of the time, treatment of primary hypertriglyceridemia consists of nonpharmacologic therapy (weight reduction in overweight patients, alcohol restriction, and increased physical activity). In type I hypertriglyceridemia with lipoprotein lipase deficiency, a very low fat diet ( 4 0 g/day) should be performed (5,6). Drug therapy using fibric acids or nicotinic acid should be used for patients (except those with type I hyperlipoproteinemia) who fail to respond to the nonpharmacologic methods ( 5 ) . In some cases, triglyceride levels often remain grossly elevated (> 11.3 mM or 1,000 mg/dl) because patients did not accept diet nor pharmacologic treatment. In these cases, recurrent acute pancreatitis can occur. We report the first use of regular plasmapheresis in prevention of recurrent acute pancreatitis in two patients with severe hypertriglyceridemia.
Our study shows that plasma triglyceride levels remained elevated during the regular plasmapheresis period. Means of the triglyceride levels before plasmapheresis were as high as 16.4 mM ( I ,450 mg/ dl, patient I ) and 27.8 mM (2,460 mg/dl, patient 2). One explanation of this unexpected result is that patients do not strictly adhere to diet, especially in type I hyperlipoproteinemia (patient 11, in which a very low fat diet is required (5, 6) . In fact, patients reported alcohol abuse or fat abuse during the days just before the plasma exchange. Perhaps it would be better to diminish the interval between each plasma exchange, but plasmapheresis is a constraining method for the patient and the cost of each procedure is high. The cost per procedure is $1,300 (including disposable materials, replacement fluid, and professional fees) in Europe. However, only one pancreatitis episode occurred during a total follow-up of 5.8 years in patient 1 after 32 months of treatment, whereas 12 episodes occurred in both patients over a period of 8 years (5 and 3 years, respectively ) before plasma exchange therapy. The relationship of very high triglyceride levels to headaches, dizziness, and vertigo is not clear. Hypertriglyceridemia could probably be responsible for hyperviscosity syndrome. So it is not surprising to observe an improvement of dizziness after plasmapheresis in patient 2. Such an effect has already been reported in the literature (17) .
Although many complications of plasma exchanges are described in the literature (18,191, we did not report side effects. Each procedure was very well tolerated. The use of heated albumin as replacement fluid did not expose patients to the risks of transmission of hepatitis viruses or human immunodeficiency virus.
To remove plasma triglycerides, we used plasma- Risks of infections and bleeding are theoretically reduced with lipapheresis compared to plasma exchange. In point of fact, we never observed these complications during the study. Low-density lipoproteins apheresis is used for severe familial hypercholesterolemia. This method can be performed using heparin agarose beads or columns containing anti-apoliproprotein B antibodies or columns containing dextran sulfate cellulose (20) . But this procedure is more expensive than plasma exchange, due to the high cost of material. Moreover, by using immunoapheresis rather than plasmapheresis, the removal of triglyceride-rich lipoproteins is less efficient in type I hyperlipoproteinemia because the protein composition of chylomicrons (apoprotein B48) is only 2% (21) . So the binding domain is not sufficiently exposed for interaction with the column. Apheresis could be more useful in type IV or V hyperlipoproteinemia, because the amount of apoprotein is higher in very low density lipoproteins and protein binding domains are more exposed. Some authors used an apheresis column coated with anti-apolipoprotein B antibodies (removing apoprotein B-rich lipoproteins) in treating gestational pancreatitis due to severe hypertriglyceridemia ( 12).
In conclusion, it appears that plasmapheresis is a safe and highly effective method for quickly lowering triglyceride levels in high hypertriglyceridemia. Moreover, although pancreatitis developed in one patient while he was eating meals high in fat and drinking alcohol, plasmapheresis may be useful for preventing acute pancreatitis in cases of primary hypertriglyceridemia if the plasma triglyceride levels remain elevated in spite of diet and/or drug therapy. Nevertheless, conventional therapy, especially diet, should not be discontinued.
